DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Narcolepsy Drug Market

Global Narcolepsy Drug Market Opportunities and Forecast 2020-2027

  • DLR2427
  • 15 September, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Narcolepsy Drug Market, By Disease Type (Daytime Extreme Sleepiness, Cataplexia, Others), By Therapeutics Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Others), and opportunities and forecast 2020-2027

Narcolepsy Drug Market Overview

The global Narcolepsy Drug market is projected to expand at a moderate rate during the forecast period. Factors such as increasing awareness about sleep disorders, growing incidence of these disorders due to unhealthy lifestyle, and growth in stress levels are expected to drive the global narcolepsy drug market during the forecast period.

Moreover, large-scale efforts of government and non-governmental organizations for spreading awareness about the disease along with rising R&D activities to find a cure for narcolepsy are the other important factors expected to boost the growth of the narcolepsy drug market in near future. In addition to this, growing health care expenditure and increasing demand for advanced drugs for sleeping disorders are further driving the expansion of this market globally.

On the downside, a lack of awareness among patients and health care providers about the disease in developing countries is likely to hamper the global narcolepsy drug market during the forecast period.

Narcolepsy Drug Market Segment Overview

According to Therapeutics Type, the Sodium Oxybate segment holds the largest share of the market. This is because these drugs are highly effective to treat daytime extreme sleepiness and cataplexy. The sodium oxybate is approved by the FDA to treat cataplexy and excessive daytime sleepiness.

Based on disease type, the Daytime Extreme Sleepiness segment is expected to grow at the highest rate in the coming years. Excessive daytime sleepiness is one of the most common sleep-related symptoms, and it affects an estimated 20% of the population. Also, the rising incidence of narcolepsy and other sleep disorders increases the risk of this symptom, thus it boosting the demand for narcolepsy drugs.

Narcolepsy Drug Market Regional Overview

Region-wise, North America dominated the global Narcolepsy Drug market and is expected to continue its dominance during the forecast period. Factors such as advanced technology, rising awareness among people about the diagnosis of the disease, and high health care expenditure propels the growth of market in North America. similarly, Europe is also expected to account for a significant share of the global market owing to well-established health care infrastructure. Additionally, the Asia Pacific is expected to register the fastest growth during the forecast period. Factors such as development in the health care infrastructure, rising awareness about health, a surge in investment in pharmaceuticals and biotechnology sectors, and high incidence of narcolepsy in countries such as Japan are expected to escalate the growth of the Narcolepsy Drug market in the Asia Pacific region.

Narcolepsy Drug Market Competitor overview

·     In June 2021, Jazz Pharmaceuticals plc. announced that the U.S. Food and Drug Administration (FDA) has recognized seven years of Orphan Drug Exclusivity for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) oral solution for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy. Xywav is an oxybate product with a unique composition of cations resulting in 92% less sodium or approximately 1,000 to 1,500 mg/night, than sodium oxybate at the recommended adult dosage range of 6 to 9 grams. 

Narcolepsy Drug Market, Key Players

·       Ligand Pharmaceuticals
·       Addrenex Pharmaceuticals
·       Shire Plc
·       Teva Pharmaceutical Industries Ltd.
·       Arena Pharmaceuticals
·       Jazz Pharmaceuticals Plc.
·       Bioprojet
·       Graymark Healthcare, Inc.

Narcolepsy Drug Market Segmentation

Narcolepsy Drug Market, By Disease Type

·       Daytime Extreme Sleepiness
·       Cataplexia
·       Others

Narcolepsy Drug Market, By Therapeutics Type

·       Central Nervous System Stimulants
·       Tricyclic Antidepressants
·       Sodium Oxybate
·       Selective Serotonin Reuptake Inhibitor
·       Others

Narcolepsy Drug Market, By Region
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa


1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

    3. Market Dynamics

    • 3.1. Market Drivers
    • 3.2. Market Restraints
    • 3.3. Market Opportunities

    4. Key Insights

    • 4.1. Key Emerging Trends – For Major Countries
    • 4.2. Latest Technological Advancement
    • 4.3. Regulatory Landscape
    • 4.4. Industry SWOT Analysis
    • 4.5. Porters Five Forces Analysis

    5. Global Narcolepsy Drug Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 5.1. Key Findings / Summary
    • 5.2. Market Analysis, Insights and Forecast – By Disease Type
      • 5.2.1. Daytime Extreme Sleepiness
      • 5.2.2. Cataplexia
      • 5.2.3. Others
    • 5.3. Market Analysis, Insights and Forecast – By Therapeutics Type
      • 5.3.1. Central Nervous System Stimulants
      • 5.3.2. Tricyclic Antidepressants
      • 5.3.3. Sodium Oxybate
      • 5.3.4. Selective Serotonin Reuptake Inhibitor
      • 5.3.5. Others
    • 5.4. Market Analysis, Insights and Forecast – By Region
      • 5.4.1. North America
      • 5.4.2. Latin America
      • 5.4.3. Europe
      • 5.4.4. Asia Pacific
      • 5.4.5. Middle East and Africa

    6. North America Narcolepsy Drug Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 6.1. Key Findings / Summary
    • 6.2. Market Analysis, Insights and Forecast – By Disease Type
      • 6.2.1. Daytime Extreme Sleepiness
      • 6.2.2. Cataplexia
      • 6.2.3. Others
    • 6.3. Market Analysis, Insights and Forecast – By Therapeutics Type
      • 6.3.1. Central Nervous System Stimulants
      • 6.3.2. Tricyclic Antidepressants
      • 6.3.3. Sodium Oxybate
      • 6.3.4. Selective Serotonin Reuptake Inhibitor
      • 6.3.5. Others
    • 6.4. Market Analysis, Insights and Forecast – By Country
      • 6.4.1. U.S.
      • 6.4.2. Canada

    7. Latin America Narcolepsy Drug Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 7.1. Key Findings / Summary
    • 7.2. Market Analysis, Insights and Forecast – By Disease Type
      • 7.2.1. Daytime Extreme Sleepiness
      • 7.2.2. Cataplexia
      • 7.2.3. Others
    • 7.3. Market Analysis, Insights and Forecast – By Therapeutics Type
      • 7.3.1. Central Nervous System Stimulants
      • 7.3.2. Tricyclic Antidepressants
      • 7.3.3. Sodium Oxybate
      • 7.3.4. Selective Serotonin Reuptake Inhibitor
      • 7.3.5. Others
    • 7.4. Market Analysis, Insights and Forecast – By Country
      • 7.4.1. Brazil
      • 7.4.2. Mexico
      • 7.4.3. Rest of Latin America

    8. Europe Narcolepsy Drug Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 8.1. Key Findings / Summary
    • 8.2. Market Analysis, Insights and Forecast – By Disease Type
      • 8.2.1. Daytime Extreme Sleepiness
      • 8.2.2. Cataplexia
      • 8.2.3. Others
    • 8.3. Market Analysis, Insights and Forecast – By Therapeutics Type
      • 8.3.1. Central Nervous System Stimulants
      • 8.3.2. Tricyclic Antidepressants
      • 8.3.3. Sodium Oxybate
      • 8.3.4. Selective Serotonin Reuptake Inhibitor
      • 8.3.5. Others
    • 8.4. Market Analysis, Insights and Forecast – By Country
      • 8.4.1. UK
      • 8.4.2. Germany
      • 8.4.3. France
      • 8.4.4. Italy
      • 8.4.5. Spain
      • 8.4.6. Russia
      • 8.4.7. Rest of Europe

    9. Asia Pacific Narcolepsy Drug Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 9.1. Key Findings / Summary
    • 9.2. Market Analysis, Insights and Forecast – By Disease Type
      • 9.2.1. Daytime Extreme Sleepiness
      • 9.2.2. Cataplexia
      • 9.2.3. Others
    • 9.3. Market Analysis, Insights and Forecast – By Therapeutics Type
      • 9.3.1. Central Nervous System Stimulants
      • 9.3.2. Tricyclic Antidepressants
      • 9.3.3. Sodium Oxybate
      • 9.3.4. Selective Serotonin Reuptake Inhibitor
      • 9.3.5. Others
    • 9.4. Market Analysis, Insights and Forecast – By Country
      • 9.4.1. China
      • 9.4.2. India
      • 9.4.3. Japan
      • 9.4.4. Australia
      • 9.4.5. South East Asia
      • 9.4.6. Rest of Asia Pacific

    10. Middle East & Africa Narcolepsy Drug Market Analysis (USD Billion), Insights and Forecast, 2020-2027

    • 10.1. Key Findings / Summary
    • 10.2. Market Analysis, Insights and Forecast – By Disease Type
      • 10.2.1. Daytime Extreme Sleepiness
      • 10.2.2. Cataplexia
      • 10.2.3. Others
    • 10.3. Market Analysis, Insights and Forecast – By Therapeutics Type
      • 10.3.1. Central Nervous System Stimulants
      • 10.3.2. Tricyclic Antidepressants
      • 10.3.3. Sodium Oxybate
      • 10.3.4. Selective Serotonin Reuptake Inhibitor
      • 10.3.5. Others
    • 10.4. Market Analysis, Insights and Forecast – By Country
      • 10.4.1. GCC
      • 10.4.2. South Africa
      • 10.4.3. Rest of Middle East & Africa

    11. Competitive Analysis

    • 11.1. Company Market Share Analysis, 2018
    • 11.2. Key Industry Developments
    • 11.3. Company Profile
    • 11.4. Ligand Pharmaceuticals
      • 11.4.1. Business Overview
      • 11.4.2. Segment 1 & Service Offering
      • 11.4.3. Overall Revenue
      • 11.4.4. Geographic Presence
      • 11.4.5. Recent Development
    *Similar details will be provided for the following companies
    • 11.5. Addrenex Pharmaceuticals
    • 11.6. Shire Plc
    • 11.7. Teva Pharmaceutical Industries Ltd.
    • 11.8. Arena Pharmaceuticals
    • 11.9. Jazz Pharmaceuticals Plc.
    • 11.10. Bioprojet
    List of Figures

    Figure 1: Global Narcolepsy Drug Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
    Figure 2: Global Narcolepsy Drug Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 3: Global Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 4: Global Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 5: Global Narcolepsy Drug Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 6: Global Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 7: Global Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 8: Global Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 9: Global Narcolepsy Drug Market Forecast (USD Billion), by Others, 2016-2027
    Figure 10: Global Narcolepsy Drug Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 11: Global Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 12: Global Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 13: Global Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 14: Global Narcolepsy Drug Market Forecast (USD Billion), by Others, 2016-2027
    Figure 15: Global Narcolepsy Drug Market Value (USD Billion), by Region, 2019 & 2027
    Figure 16: North America Narcolepsy Drug Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 17: North America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 18: North America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 19: North America Narcolepsy Drug Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 20: North America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 21: North America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 22: North America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 23: North America Narcolepsy Drug Market Forecast (USD Billion), by Others, 2016-2027
    Figure 24: North America Narcolepsy Drug Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 25: North America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 26: North America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 27: North America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 28: North America Narcolepsy Drug Market Forecast (USD Billion), by Others, 2016-2027
    Figure 29: North America Narcolepsy Drug Market Forecast (USD Billion), by U.S., 2016-2027
    Figure 30: North America Narcolepsy Drug Market Forecast (USD Billion), by Canada, 2016-2027
    Figure 31: Latin America Narcolepsy Drug Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 32: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 33: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 34: Latin America Narcolepsy Drug Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 35: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 36: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 37: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 38: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Others, 2016-2027
    Figure 39: Latin America Narcolepsy Drug Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 40: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 41: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 42: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 43: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Others, 2016-2027
    Figure 44: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Brazil, 2016-2027
    Figure 45: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Mexico, 2016-2027
    Figure 46: Latin America Narcolepsy Drug Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
    Figure 47: Europe Narcolepsy Drug Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 48: Europe Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 49: Europe Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 50: Europe Narcolepsy Drug Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 51: Europe Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 52: Europe Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 53: Europe Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 54: Europe Narcolepsy Drug Market Forecast (USD Billion), by Others, 2016-2027
    Figure 55: Europe Narcolepsy Drug Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 56: Europe Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 57: Europe Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 58: Europe Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 59: Europe Narcolepsy Drug Market Forecast (USD Billion), by Others, 2016-2027
    Figure 60: Europe Narcolepsy Drug Market Forecast (USD Billion), by U.K., 2016-2027
    Figure 61: Europe Narcolepsy Drug Market Forecast (USD Billion), by Germany, 2016-2027
    Figure 62: Europe Narcolepsy Drug Market Forecast (USD Billion), by France, 2016-2027
    Figure 63: Europe Narcolepsy Drug Market Forecast (USD Billion), by Italy, 2016-2027
    Figure 64: Europe Narcolepsy Drug Market Forecast (USD Billion), by Spain, 2016-2027
    Figure 65: Europe Narcolepsy Drug Market Forecast (USD Billion), by Russia, 2016-2027
    Figure 66: Europe Narcolepsy Drug Market Forecast (USD Billion), by Rest of Europe, 2016-2027
    Figure 67: Asia Pacific Narcolepsy Drug Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 68: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 69: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 70: Asia Pacific Narcolepsy Drug Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 71: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 72: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 73: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 74: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Others, 2016-2027
    Figure 75: Asia Pacific Narcolepsy Drug Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 76: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 77: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 78: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 79: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Others, 2016-2027
    Figure 80: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by China, 2016-2027
    Figure 81: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by India, 2016-2027
    Figure 82: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Japan, 2016-2027
    Figure 83: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Australia, 2016-2027
    Figure 84: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Southeast Asia, 2016-2027
    Figure 85: Asia Pacific Narcolepsy Drug Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
    Figure 86: Middle East & Africa Narcolepsy Drug Market Value Share (%), By Segment 1, 2019 & 2027
    Figure 87: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 88: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 89: Middle East & Africa Narcolepsy Drug Market Value Share (%), By Segment 2, 2019 & 2027
    Figure 90: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 91: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 92: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 93: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by Others, 2016-2027
    Figure 94: Middle East & Africa Narcolepsy Drug Market Value Share (%), By Segment 3, 2019 & 2027
    Figure 95: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
    Figure 96: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
    Figure 97: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
    Figure 98: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by Others, 2016-2027
    Figure 99: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by GCC, 2016-2027
    Figure 100: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by South Africa, 2016-2027
    Figure 101: Middle East & Africa Narcolepsy Drug Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
    List of Tables
    Table 1: Global Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 2: Global Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 3: Global Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 4: Global Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Region, 2016-2027
    Table 5: North America Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 6: North America Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 7: North America Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 8: North America Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Table 9: Europe Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 10: Europe Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 11: Europe Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 12: Europe Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Table 13: Latin America Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 14: Latin America Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 15: Latin America Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 16: Latin America Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Table 17: Asia Pacific Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 18: Asia Pacific Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 19: Asia Pacific Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 20: Asia Pacific Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Country, 2016-2027
    Table 21: Middle East & Africa Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
    Table 22: Middle East & Africa Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
    Table 23: Middle East & Africa Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
    Table 24: Middle East & Africa Narcolepsy Drug Market Revenue (USD Billion) Forecast, by Country, 2016-2027

    Report You Might be Interested

    Choose License Type

    • USD
    • GBP
    • EURO
    • INR
    Credit card Logo

    Happy To Assist You

    Have a Question? email us at

    info@datalibraryresearch.com

    Or Call Us On

    US +1 360 851 1343

    IND +91 880 579 4934